A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)
NCT03316794
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class
Stopped
Strategic considerations
Conditions
Breast Cancer
Interventions
DRUG:
SC-005
Sponsor
AbbVie